Dogwood Therapeutics, Inc. (DWTX)
NASDAQ: DWTX · Real-Time Price · USD
1.380
+0.010 (0.73%)
At close: Jul 17, 2026, 4:00 PM EDT
1.389
+0.009 (0.67%)
After-hours: Jul 17, 2026, 7:27 PM EDT
Dogwood Therapeutics Market Cap
Dogwood Therapeutics has a market cap or net worth of $46.41 million as of July 17, 2026. Its market cap has increased by 439.63% in one year.
Market Cap
46.41M
Enterprise Value
33.33M
1-Year Change
439.63%
Ranking
Category
Stock Price
$1.38
ChartMarket Cap Chart
Since December 17, 2020, Dogwood Therapeutics's market cap has decreased from $130.88M to $46.41M, a decrease of -64.54%. That is a compound annual growth rate of -16.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 46.41M | -62.47% |
| Dec 31, 2025 | 123.67M | 3,628.17% |
| Dec 31, 2024 | 3.32M | -70.04% |
| Dec 29, 2023 | 11.07M | 155.97% |
| Dec 30, 2022 | 4.33M | -89.85% |
| Dec 31, 2021 | 42.61M | -27.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Filana Therapeutics | 51.21M |
| eXoZymes | 51.04M |
| INmune Bio | 50.51M |
| Instil Bio | 50.32M |
| aTyr Pharma | 49.99M |
| Mereo BioPharma Group | 49.50M |
| Radiopharm Theranostics | 49.50M |
| Impact BioMedical | 49.17M |